• Japanese
  • Korean
  • Chinese
Cover Image

Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms

Abstract

Summary

GBI Research analyzes the veterinary vaccines market up to 2017. The report examines the market by analyzing livestock species including bovine, ovine, equine and porcine. The target population considered is the total animal population in each respective region. The report specifically covers livestock species excluding companion animals, and concludes that the livestock market sector has shown steady growth in recent years. Biotechnology developments and research contributed tremendously towards the growth and enhancement of the veterinary vaccines market. Europe and the US collectively hold more than 70% of the total market.

The market grew at a steady rate for the past few years and is expected to grow further. The demand for veterinary vaccines in the market is driven by factors such as the vulnerability of animals to fatal and chronic diseases, and the changing patterns of the diseases. The recent epidemics created awareness among livestock owners of the need to avoid the huge production losses due to diseases such as swine flu, avian influenza and anthrax. The future of vaccines will be dominated by DNA-related vaccines and combination vaccines, which can provide protection against various diseases with minimal vaccine shots. Such innovative products will be more capable of providing protection and generating a strong immune response than the traditional vaccines.

The key players in the veterinary vaccines market are Bayer HealthCare, Merck & Co. Inc., Fort Dodge Animal Health, Novartis Animal Heath, Pfizer, Lohmann Animal Health, Merial Ltd., Boehringer Ingelheim GmbH, and Heska Corporation. There are many other companies which are involved with the manufacturing and development of veterinary vaccines apart from those in the list.

Scope

  • Annualized market data for the veterinary vaccines market from 2002 to 2010, forecast forward to 2017.
  • Analysis of the leading livestock segments, including bovine, ovine, porcine and equine.
  • Analysis of the veterinary vaccines market in the leading geographies of the world, which include the US, Europe and Japan.
  • Market characterization of the veterinary vaccines market, including market size, annual cost of vaccination and target population.
  • Key drivers and barriers that have a significant impact on the market.
  • Competitive benchmarking of leading companies. The key companies studied in this report are Bayer, Pfizer, Merck and Novartis.
  • Key M&A activities and licensing agreements that have taken place in the veterinary vaccines market.

Reasons to buy

  • Align your product portfolio to the markets with high growth potential.
  • Develop market-entry and market expansion strategies by identifying the leading livestock segments and geographic markets poised for strong growth.
  • Develop key strategic initiatives by understanding the key focus areas of leading companies and niche companies which are helpful in extending the pipeline portfolio.
  • Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

Executive Summary

GBI Research, the leading business intelligence provider, has released its latest research, “Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms”. The report analyzes the markets for veterinary vaccines, covering bovine, ovine, porcine and equine species in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), and Japan. The report also provides geographical landscape, competitive landscape, product profiles, and analysis of drivers and barriers that impact the veterinary vaccines market. Furthermore, the report provides company profiling, SWOT analysis for the leading companies, and analysis of the mergers, acquisitions, recent activities and licensing agreements that shape the global markets.

The veterinary vaccines market has shown growth over recent years, which can be attributed to good animal husbandry practices and better management of farms. This results in the estimation of further growth in the market due to the advancement in biotechnological research and the tremendous development in the innovation of new vaccines for various diseases.

The Global Veterinary Vaccines Market Will Witness Consistent Growth with Europe to Continue to Dominate

The global veterinary vaccines market grew at the rate of 1% from 2002-2010, and is likely to witness the same growth for the period 2011-2017. The European veterinary vaccines market grew at a CAGR of 1% from 2002 to 2010. The total livestock vaccines market was estimated to be worth $2.9 billion in 2010, and is expected to grow at the same rate to reach $3.1 billion in 2017.

As per the GBI Research analysis, Europe is expected to hold a major share in the veterinary vaccines market by 2017, with $3.1 billion in revenues, whereas the US market is estimated to reach $2.9 billion, contributing 48% to the total veterinary vaccines market.

The Bovine Vaccines Market is the Largest Market Due to the Organized Dairy and Beef Producing Sectors

The bovine vaccines market is the largest livestock vaccines market. In 2017, the market size for bovine vaccines is estimated to be $3 billion, out of which the US contributes $1.6 billion, Europe $1.3 billion, and Japan $70.4m. The market is expected to grow at the rate of 0.7% in the US and Europe.

The dairy and beef sectors are being converted into organized sectors in the developed countries, and a proper vaccination schedule is being followed. This is one of the main reasons for the growth in the bovine vaccines market.

The annual cost of vaccination (ACV) in the US was $12.9 for a cow-calf unit in 2002, and grew at a rate of 2.4% to reach $15.6 per cow-calf unit in 2010. A cow-calf unit refers to a unit which includes a cow with one or two calves. The ACV is estimated to grow from $15.6 to $17.6, at a CAGR of 2% for a cow-calf unit for the forecast period between 2010 and 2017.

The Ovine Vaccines Market is One of the Fastest Growing Veterinary Vaccines Markets in the US, With an Estimated Growth Rate of 4% between 2010 and 2017

The sheep vaccines market in the US grew at the rate of 13.7% from 2002 to 2010. The market was estimated at $22.1m in 2010, and is expected to grow at the rate of 4% from 2010 to 2017. The estimated market size in 2017 is $29.2m. This market is estimated to grow at the fastest rate (4%) among all the livestock vaccines markets. The sheep population in the US grew at a rate of 3% from 2002 to 2010. The total sheep population in the US was estimated at 3.2 million for 2010. The population is estimated to be 3.9 million by 2017. The population is expected to grow with the same rate for the next seven years.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GBI Research Report Guidance

3. Veterinary Vaccines Market to 2017 - Market Overview

  • 3.1. Revenue Forecasts
  • 3.2. Drivers
    • 3.2.1. Livestock Owners Developing Increased Disease Awareness for Farm Animals
  • 3.3. Barriers
    • 3.3.1. Mutant Strains of Virus Pose a Challenge in Vaccine Manufacturing
    • 3.3.2. Decrease in Cattle Population is Reducing the Demand for Vaccines

4. Veterinary Vaccines Market to 2017 - Geographical Landscape

  • 4.1. The US
    • 4.1.1. Revenue Forecast
  • 4.2. Europe
    • 4.2.1. Revenue Forecast
  • 4.3. Japan
    • 4.3.1. Revenue Forecast

5. Veterinary Vaccines Market to 2017 - Bovine Vaccines Market

  • 5.1. The US
    • 5.1.1. Revenue Forecasts
    • 5.1.2. Annual Cost of Vaccination
    • 5.1.3. Target Population
  • 5.2. Europe
    • 5.2.1. Revenue Forecasts
    • 5.2.2. Annual Cost of Vaccination
    • 5.2.3. Target Population
  • 5.3. Japan
    • 5.3.1. Revenue Forecasts
    • 5.3.2. Annual Cost of Vaccination
    • 5.3.3. Target Population

6. Veterinary Vaccines Market to 2017 - Ovine Vaccines Market

  • 6.1. The US (Sheep Vaccines Market)
    • 6.1.1. Revenue Forecasts
    • 6.1.2. Annual Cost of Vaccination
    • 6.1.3. Target Population
  • 6.2. Europe (Sheep Vaccine Market)
    • 6.2.1. Revenue Forecasts
    • 6.2.2. Annual Cost of Vaccination
    • 6.2.3. Target Population
  • 6.3. Japan (Sheep Vaccines Market)
    • 6.3.1. Revenue Forecasts
    • 6.3.2. Annual Cost of Vaccination
    • 6.3.3. Target Population
  • 6.4. The US (Goat Vaccines Market)
    • 6.4.1. Revenue Forecasts
    • 6.4.2. Annual Cost of Vaccination
    • 6.4.3. Target Population
  • 6.5. Europe (Goat Vaccines Market)
    • 6.5.1. Revenue Forecasts
    • 6.5.2. Annual Cost of Vaccination
    • 6.5.3. Target Population
  • 6.6. Japan (Goat Vaccines Market)
    • 6.6.1. Revenue Forecasts
    • 6.6.2. Annual Cost of Vaccination
    • 6.6.3. Target Population

7. Veterinary Vaccines Market to 2017 - Porcine Vaccines Market

  • 7.1. The US
    • 7.1.1. Revenue Forecasts
    • 7.1.2. Annual Cost of Vaccination
    • 7.1.3. Target Population
  • 7.2. Europe
    • 7.2.1. Revenue Forecasts
    • 7.2.2. Annual Cost of Vaccination
    • 7.2.3. Target Population
  • 7.3. Japan
    • 7.3.1. Revenue Forecasts
    • 7.3.2. Annual Cost of Vaccination
    • 7.3.3. Target Population

8. Veterinary Vaccines Market to 2017 - Equine Vaccines Market

  • 8.1. The US
    • 8.1.1. Revenue Forecasts
    • 8.1.2. Annual Cost of Vaccination
    • 8.1.3. Target Population
  • 8.2. Europe
    • 8.2.1. Revenue Forecasts
    • 8.2.2. Annual Cost of Vaccination
    • 8.2.3. Target Population
  • 8.3. Japan
    • 8.3.1. Revenue Forecasts
    • 8.3.2. Annual Cost of Vaccination
    • 8.3.3. Target Population

9. Veterinary Vaccines Market to 2017 - Competitive Landscape

  • 9.1. Company Profiles
    • 9.1.1. Bayer HealthCare
    • 9.1.2. Pfizer
    • 9.1.3. Merck Inc.
    • 9.1.4. Novartis

10. Veterinary Vaccines Market to 2017 - Product Profiles

  • 10.1. Bovine Vaccines
    • 10.1.1. Alpha-7
    • 10.1.2. Vira Shield 6 + VL5
    • 10.1.3. Salmonella Newport Bacterial Extract SRP
    • 10.1.4. Imrab Large Animal
    • 10.1.5. Anthrax Spore Vaccine
    • 10.1.6. J-5 E. Coli Bacterin
  • 10.2. Ovine Vaccines
    • 10.2.1. Ultrabac 7
    • 10.2.2. Ultrabac CD
    • 10.2.3. Clostri Shield 7
  • 10.3. Porcine Vaccines
    • 10.3.1. Parvo Shield L5E
    • 10.3.2. Porcine Pili Shield+C
    • 10.3.3. LitterGuard LT-C
    • 10.3.4. Farrowsure Gold B
  • 10.4. Equine Vaccines
    • 10.4.1. Recombitek Equine West Nile Virus Vaccine
    • 10.4.2. Fluvac Innovator 6
    • 10.4.3. Prestige V + VEE
    • 10.4.4. Potomavac
    • 10.4.5. Imrab 3

11. Veterinary Vaccines Market to 2017 - Mergers & Acquisitions

  • 11.1. Phibro Animal Health Completed Acquisition of Abic Animal Health in February 2009
  • 11.2. Ceva Acquired Vetech Laboratories in October 2011
  • 11.3. Ceva Acquired CentaurVA Animal Health in October 2011
  • 11.4. Harbin Pharma Acquired Pfizer's Swine Vaccine Business in June 2010
  • 11.5. Boehringer Ingelheim Animal Health Acquires a Significant Portion of the Fort Dodge Animal Health Business from Pfizer in October 2009
  • 11.6. Pfizer Acquired Microtek International in May 2010
  • 11.7. Virbac Acquired Certain Veterinary Products from Pfizer in February 2010

12. Veterinary Vaccines Market to 2017 - Licensing Agreements

  • 12.1. Heska Corporation Amends Bovine Vaccine Agreement with AgriLabs
  • 12.2. Pfizer Animal Health Inks Global Licensing Deal with Epitopix
  • 12.3. GenVec Enters into Collaboration with Merial to Develop and Commercialize FMD Vaccine
  • 12.4. Vical Enters into Agreement with Japanese Partner for Veterinary Pandemic Influenza Vaccine

13. Veterinary Vaccines Market to 2017 - Recent Activities

  • 13.1. Intervet's Equine West Nile Vaccine Approved by USDA (United States Department of Agriculture)
  • 13.2. Defra Launched Bovine Tuberculosis Vaccine
  • 13.3. Boehringer Ingelheim Vetmedica Receives Approval for Express FP and Express Vaccines from the USDA

14. Veterinary Vaccines Market to 2017 - Appendix

  • 14.1. Market Definitions
  • 14.2. Abbreviations
  • 14.3. Research Methodology
    • 14.3.1. Coverage
    • 14.3.2. Secondary Research
    • 14.3.3. Primary Research
  • 14.4. Therapeutic Landscape
    • 14.4.1. Market Size by Geography
  • 14.5. Geographical Landscape
  • 14.6. Competitive Landscape
    • 14.6.1. Expert Panel Validation
  • 14.7. Contact Us
  • 14.8. Disclaimer
  • 14.9. Sources

List of Tables

  • Table 1: Veterinary Vaccines Market to 2017, Global, Revenues ($bn), 2002-2010
  • Table 2: Veterinary Vaccines Market to 2017, Global, Revenue Forecast ($bn), 2010-2017
  • Table 3: Veterinary Vaccines Market to 2017, The US, Revenues ($m), 2002-2010
  • Table 4: Veterinary Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010-2017
  • Table 5: Veterinary Vaccines Market to 2017, Europe, Revenue ($m), 2002-2010
  • Table 6: Veterinary Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010-2017
  • Table 7: Veterinary Vaccines Market to 2017, Japan, Revenues ($m), 2002-2010
  • Table 8: Veterinary Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010-2017
  • Table 9: Bovine Vaccines Market to 2017, The US, Revenue ($m), 2002-2010
  • Table 10: Bovine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010-2017
  • Table 11: Bovine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($),2002-2010
  • Table 12: Bovine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($),2010-2017
  • Table 13: Bovine Vaccines Market to 2017, The US, Target Population, (million), 2002-2010
  • Table 14: Bovine Vaccines Market to 2017, The US, Target Population, (million), 2010-2017
  • Table 15: Bovine Vaccines Market to 2017, Europe, Revenues ($m), 2002-2010
  • Table 16: Bovine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010-2017
  • Table 17: Bovine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002-2010
  • Table 18: Bovine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010-2017
  • Table 19: Bovine Vaccines Market to 2017, Europe, Target Population, (million), 2002-2010
  • Table 20: Bovine Vaccines Market to 2017, Europe, Target Population, (million), 2010-2017
  • Table 21: Bovine Vaccines Market to 2017, Japan, Revenue ($m), 2002-2010
  • Table 22: Bovine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010-2017
  • Table 23: Bovine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2010
  • Table 24: Bovine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010-2017
  • Table 25: Bovine Vaccines Market to 2017, Japan, Target Population, (million), 2002-2010
  • Table 26: Bovine Vaccines Market to 2017, Japan, Target Population, (million), 2010-2017
  • Table 27: Sheep Vaccines Market to 2017, The US, Revenue ($m), 2002-2010
  • Table 28: Sheep Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010-2017
  • Table 29: Sheep Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002-2010
  • Table 30: Sheep Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010-2017
  • Table 31: Sheep Vaccines Market to 2017, The US, Target Population (million), 2002-2010
  • Table 32: Sheep Vaccines Market to 2017, The US, Target Population (million), 2010-2017
  • Table 33: Sheep Vaccines Market to 2017, Europe, Revenue ($m), 2002-2010
  • Table 34: Sheep Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010-2017
  • Table 35: Sheep Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002-2010
  • Table 36: Sheep Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010-2017
  • Table 37: Sheep Vaccines Market to 2017, Europe, Target Population (million), 2002-2010
  • Table 38: Sheep Vaccines Market to 2017, Europe, Target Population (million), 2010-2017
  • Table 39: Sheep Vaccines Market to 2017, Japan, Revenue ($), 2002-2010
  • Table 40: Sheep Vaccines Market to 2017, Japan, Revenue Forecast ($), 2010-2017
  • Table 41: Sheep Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2010
  • Table 42: Sheep Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010-2017
  • Table 43: Sheep Vaccines Market to 2017, Japan, Target Population, 2002-2010
  • Table 44: Sheep Vaccines Market to 2017, Japan, Target Population, 2010-2017
  • Table 45: Goat Vaccines Market to 2017, The US, Revenue ($m), 2002-2010
  • Table 46: Goat Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010-2017
  • Table 47: Goat Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002-2010
  • Table 48: Goat Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010-2017
  • Table 49: Goat Vaccines Market to 2017, The US, Target Population (million), 2002-2010
  • Table 50: Goat Vaccines Market to 2017, The US, Target Population (million), 2010-2017
  • Table 51: Goat Vaccines Market to 2017, Europe, Revenue ($m), 2002-2010
  • Table 52: Goat Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010-2017
  • Table 53: Goat Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002-2010
  • Table 54: Goat Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010-2017
  • Table 55: Goat Vaccines Market to 2017, Europe, Target Population (million), 2002-2010
  • Table 56: Goat Vaccines Market to 2017, Europe, Target Population (million), 2010-2017
  • Table 57: Goat Vaccines Market to 2017, Japan, Revenue, $000's, 2002-2010
  • Table 58: Goat Vaccines Market to 2017, Japan, Revenue Forecast, $000's, 2010-2017
  • Table 59: Goat Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2010
  • Table 60: Goat Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010-2017
  • Table 61: Goat Vaccines Market to 2017, Japan, Target Population, 2002-2010
  • Table 62: Goat Vaccines Market to 2017, Japan, Target Population, 2010-2017
  • Table 63: Porcine Vaccines Market to 2017, The US, Revenue ($m), 2002-2010
  • Table 64: Porcine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010-2017
  • Table 65: Porcine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002-2010
  • Table 66: Porcine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010-2017
  • Table 67: Porcine Vaccines Market to 2017, The US, Target Population (million), 2002-2010
  • Table 68: Porcine Vaccines Market to 2017, The US, Target Population (million), 2010-2017
  • Table 69: Porcine Vaccines Market to 2017, Europe, Revenue ($m), 2002-2010
  • Table 70: Porcine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010-2017
  • Table 71: Porcine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002-2010
  • Table 72: Porcine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010-2017
  • Table 73: Porcine Vaccines Market to 2017, Europe, Target Population, (million), 2002-2010
  • Table 74: Porcine Vaccines Market to 2017, Europe, Target Population, (million), 2010-2017
  • Table 75: Porcine Vaccines Market to 2017, Japan, Revenue ($m), 2002-2010
  • Table 76: Porcine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010-2017
  • Table 77: Porcine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2010
  • Table 78: Porcine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010-2017
  • Table 79: Porcine Vaccines Market to 2017, Japan, Target Population (million), 2002-2010
  • Table 80: Porcine Vaccines Market to 2017, Japan, Target Population (million), 2010-2017
  • Table 81: Equine Vaccines Market to 2017, The US, Revenue ($m), 2002-2010
  • Table 82: Equine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2010-2017
  • Table 83: Equine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002-2010
  • Table 84: Equine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2010-2017
  • Table 85: Equine Vaccines Market to 2017, The US, Target Population (000's), 2002-2010
  • Table 86: Equine Vaccines Market to 2017, The US, Target Population (000's), 2010-2017
  • Table 87: Equine Vaccines Market to 2017, Europe, Revenue ($m), 2002-2010
  • Table 88: Equine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2010-2017
  • Table 89: Equine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002-2010
  • Table 90: Equine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2010-2017
  • Table 91: Equine Vaccines Market to 2017, Europe, Target Population, 000's, 2002-2010
  • Table 92: Equine Vaccines Market to 2017, Europe, Target Population, 000's, 2010-2017
  • Table 93: Equine Vaccines Market to 2017, Japan, Revenue ($m), 2002-2010
  • Table 94: Equine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2010-2017
  • Table 95: Equine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2010
  • Table 96: Equine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2010-2017
  • Table 97: Equine Vaccines Market to 2017, Japan, Target Population, 000's, 2002-2010
  • Table 98: Equine Vaccines Market to 2017, Japan, Target Population, 000's, 2010-2017
  • Table 99: Veterinary Vaccines Market to 2017, Product Portfolio, Bayer HealthCare, 2011
  • Table 100:Veterinary Vaccines Market to 2017, Product Portfolio, Pfizer Animal Health, 2011
  • Table 101:Veterinary Vaccines Market to 2017, Product Portfolio, Merck Inc., 2011

List of Figures

  • Figure 1: Veterinary Vaccines Market to 2017, Global, Revenue Forecast ($bn), 2002-2017
  • Figure 2: Veterinary Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002-2017
  • Figure 3: Veterinary Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002-2017
  • Figure 4: Veterinary Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2002-2017
  • Figure 5: Bovine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002-2017
  • Figure 6: Bovine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($),2002-2017
  • Figure 7: Bovine Vaccines Market to 2017, The US, Target Population, (million), 2002-2017
  • Figure 8: Bovine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002-2017
  • Figure 9: Bovine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002-2017
  • Figure 10: Bovine Vaccines Market to 2017, Europe, Target Population, (million), 2002-2017
  • Figure 11: Bovine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2002-2017
  • Figure 12: Bovine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($),2002-2017
  • Figure 13: Bovine Vaccines Market to 2017, Japan, Target Population, (million), 2002-2017
  • Figure 14: Sheep Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002-2017
  • Figure 15: Sheep Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002-2017
  • Figure 16: Sheep Vaccines Market to 2017, The US, Target Population (million), 2002-2017
  • Figure 17: Sheep Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002-2017
  • Figure 18: Sheep Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002-2017
  • Figure 19: Sheep Vaccines Market to 2017, Europe, Target Population (million), 2002-2017
  • Figure 20: Sheep Vaccines Market to 2017, Japan, Revenue Forecast ($), 2002-2017
  • Figure 21: Sheep Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2017
  • Figure 22: Sheep Vaccines Market to 2017, Japan, Target Population, 2002-2017
  • Figure 23: Goat Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002-2017
  • Figure 24: Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002-2017
  • Figure 25: Goat Vaccines Market to 2017, The US, Target Population (million), 2002-2017
  • Figure 26: Goat Vaccines Market to 2017, Europe, Revenue ($m), 2002-2017
  • Figure 27: Goat Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002-2017
  • Figure 28: Goat Vaccines Market to 2017, Europe, Target Population (million), 2002-2017
  • Figure 29: Goat Vaccines Market to 2017, Japan, Revenue Forecast, $000's, 2002-2017
  • Figure 30: Goat Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2017
  • Figure 31: Goat Vaccines Market to 2017, Japan, Target Population, 2002-2017
  • Figure 32: Porcine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002-2017
  • Figure 33: Porcine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002-2017
  • Figure 34: Porcine Vaccines Market to 2017, The US, Target Population (million), 2002-2017
  • Figure 35: Porcine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002-2017
  • Figure 36: Porcine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002-2017
  • Figure 37: Porcine Vaccines Market to 2017, Europe, Target Population, (million), 2002-2017
  • Figure 38: Porcine Vaccines Market to 2017, Japan, Revenue ($m), 2002-2017
  • Figure 39: Porcine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2017
  • Figure 40: Porcine Vaccines Market to 2017, Japan, Target Population (million), 2002-2017
  • Figure 41: Equine Vaccines Market to 2017, The US, Revenue Forecast ($m), 2002-2017
  • Figure 42: Equine Vaccines Market to 2017, The US, Annual Cost of Vaccination ($), 2002-2017
  • Figure 43: Equine Vaccines Market to 2017, The US, Target Population (000's), 2002-2017
  • Figure 44: Equine Vaccines Market to 2017, Europe, Revenue Forecast ($m), 2002-2017
  • Figure 45: Equine Vaccines Market to 2017, Europe, Annual Cost of Vaccination ($), 2002-2017
  • Figure 46: Equine Vaccines Market to 2017, Europe, Target Population, 000's, 2002-2017
  • Figure 47: Equine Vaccines Market to 2017, Japan, Revenue Forecast ($m), 2002-2017
  • Figure 48: Equine Vaccines Market to 2017, Japan, Annual Cost of Vaccination ($), 2002-2017
  • Figure 49: Equine Vaccines Market to 2017, Japan, Target Population, 000's, 2002-2017
Show More
Pricing
Get Notified
Email me when related reports are published